Fragment-Based Lead Discovery Conference
WuXi AppTec is excited to participate in the Fragment-Based Lead Discovery (FBLD) Conference 2025, taking place September 21–24, 2025, at Fitzwilliam College, University of Cambridge, UK, co-hosted by Astex Pharmaceuticals and Monash University.
This high-quality, multidisciplinary event brings together chemistry, biochemistry, and drug discovery experts for an immersive program including talks, workshops, poster sessions, and ample networking opportunities, exploring every aspect of fragment-based drug discovery.
At WuXi AppTec, we support fragment-based drug discovery with versatile, integrated capabilities. Our offerings include cutting-edge biophysical fragment screening platforms (such as SPR, MST, and spectral shift assays), structural biology techniques for validating hits via X-ray crystallography and NMR, and tailored chemistry support to develop fragment hits into optimized lead candidates. Whether you're designing fragment libraries or advancing hits toward potency and selectivity, our comprehensive services streamline and enhance every step of the process. Our integrated offer streamlines the journey from fragment identification to lead optimization.
Looking forward to connecting in Cambridge to explore how our capabilities can elevate your FBLD programs. To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
